H. Schunkert et al., The cardiac endothelin system in established pressure overload left ventricular hypertrophy, J MOL MED-J, 77(8), 1999, pp. 623-630
Citations number
30
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
In normal hearts, endothelin-1 (ET-1) has been shown to initiate myocyte gr
owth and to modulate cardiac function. However, regulation of the various c
omponents of the system and the functional effects of ET-1 in established l
eft ventricular hypertrophy (LVH) are less clear. We thus studied ET-1, ETA
receptor, and endothelin converting enzyme (ECE-1) mRNA regulation as well
as the effects of ET-1 on coronary resistance, LV contractility and relaxa
tion in hypertrophied rat hearts. Cardiac pressure overload, secondary to b
anding of the ascending aorta, resulted in a transient increase of cardiac
ET-1 and ETA receptor mRNAs that reached a maximum at 2 days (+75% and +40%
, respectively, P<0.05, each). ET-1 mRNA levels reached a second peak at 84
days of pressure overload (+60%, P<0.05), at the later time point in conju
nction with elevated ECE-1 mRNA levels (+20%, P<0.05). The functional impli
cations of ET-1 were examined in a study of isolated perfused hearts. Both
hearts with established LVH and sham control hearts responded to ET-1 perfu
sion (10-(11) to 10(-9) M) with an increase of coronary perfusion pressure
(CPP; +85+/-15 and +75+/-8 mmHg; P<0.001 each) and a slight decrease of LV
systolic pressure (LVP; -12+/-9 and -9+/-7 mmHg; P=NS). In contrast, ET-1 i
ncreased LV end-diastolic pressure (LVEDP) only in LVH hearts (+22+/-7 mmHg
, P<0.05 versus baseline and +20 +/-7 mmHg, P<0.05 versus sham). Direct sti
mulation of protein kinase C mimicked the effects of ET-1, whereas inhibiti
on of this kinase or the Na+-H+ exchanger blunted the effects of ET-1 on CP
P, LVP, and LVEDP. Interestingly, coadministration of the vasodilator and t
he nitric oxide (NO) donor nitroglycerin not only prevented the increase of
CPP and LVEDP, but also uncovered a slight positive inotropic effect of ET
-1 in LVH hearts. Thus, the cardiac expression of ET-1, ETA, and ECE-1 mRNA
s displays a distinct pattern during early and advanced cardiac pressure ov
erload. Furthermore, ET-1 mediates a slight depression of systolic, and a p
rofound depression of diastolic, functional parameters in hearts with estab
lished LVH, effects that appear to be secondary to ET-1-related coronary va
soconstriction. The data suggest a functional role of the endothelin system
in hearts with established pressure overload hypertrophy.